When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYL - Biogen under pressure on adverse ruling Tecfidera patent ruling
Mylan N.V.
Biogen (BIIB-6.4%) is down out the gate after a West Virginia judge found that generic drugmaker Mylan (MYL+6.1%) demonstrated Biogen's U.S. patent '514 for multiple sclerosis med Tecfidera (dimethyl fumarate) was "invalid for lack of written description."
More news on: Biogen Inc., Mylan, Inc., Stocks on the move, Healthcare stocks news,